Get the full picture
Sign in to uncover key details.
PAQ Therapeutics
Business Services · Massachusetts, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
100 Summit Dr Ste 916, Burlington, Massa...Website
www.paqtx.comRevenue
<$5 MillionIndustry
About PAQ Therapeutics
PAQ Therapeutics is a biotechnology company pioneering a new approach to restoring heath and curing disease through autophagy, the body's most versatile mechanism for natural cellular degradation. With the company's ATTEC (autophagosome-tethering compound) technology, the company is developing a novel class of small molecule degraders capable of binding a diverse array of substrates to the autophagy pathway. PAQ's research advances are driving an important new class of degradation therapies with the potential to fundamentally transform drug discovery and development and target a range of substrates including proteins, aggregates, lipids, organelles and pathogens.Explore more
PAQ Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to PAQ Therapeutics
Compare insights from companies similar to PAQ Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
PAQ Therapeutics Tech Stack
A closer look at the technologies used by PAQ Therapeutics
Top Business Services Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Frequently Asked Questions Regarding PAQ Therapeutics
Sign Up For FreeTo access detailed company insights
PAQ Therapeutics is a biotechnology company pioneering a new approach to restoring heath and curing disease through autophagy, the body's most versatile mechanism for natural cellular degradation. With the company's ATTEC (autophagosome-tethering compound) technology, the company is developing a novel class of small molecule degraders capable of bi... Read More
